Financial Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$295K Hold
1,037
0.05% 76
2023
Q4
$299K Hold
1,037
0.06% 74
2023
Q3
$279K Buy
1,037
+1
+0.1% +$250 0.06% 73
2023
Q2
$230K Hold
1,036
0.05% 78
2023
Q1
$250K Hold
1,036
0.05% 73
2022
Q4
$272K Hold
1,036
0.06% 76
2022
Q3
$233K Buy
1,036
+1
+0.1% +$242 0.05% 76
2022
Q2
$252K Buy
1,035
+8
+0.8% +$1.96K 0.05% 77
2022
Q1
$248K Buy
1,027
+1
+0.1% +$230 0.05% 85
2021
Q4
$231K Sell
1,026
-1
-0.1% -$211 0.05% 87
2021
Q3
$218K Sell
1,027
-193
-16% -$44.4K 0.05% 84
2021
Q2
$297K Buy
1,220
+191
+19% +$47K 0.07% 71
2021
Q1
$256K Sell
1,029
-190
-16% -$45.3K 0.07% 71
2020
Q4
$280K Buy
1,219
+190
+18% +$43.8K 0.07% 71
2020
Q3
$262K Buy
1,029
+1
+0.1% +$248 0.08% 63
2020
Q2
$243K Sell
1,028
-1
-0.1% -$228 0.08% 64
2020
Q1
$209K Buy
1,029
+1
+0.1% +$218 0.07% 63
2019
Q4
$248K Buy
+1,028
New +$227K 0.07% 71
2019
Q1
Sell
-1,028
Closed -$200K 69
2018
Q4
$200K Buy
1,028
+1
+0.1% +$195 0.06% 67
2018
Q3
$213K Buy
+1,027
New +$202K 0.06% 64

Other funds holding AMGN

Financial Advisory Group's AMGN Position: Q1 2024 in Review

Financial Advisory Group held its Amgen (AMGN) position steady in Q1 2024 at 1,037 shares worth $295K. The position accounts for 0.05% of the portfolio, ranked #76.

Financial Advisory Group first reported a position in AMGN in Q3 2018 and has held it in 20 quarters since. The position peaked at $299K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Financial Advisory Group held 1,037 shares of Amgen worth $295K as of Q1 2024.
  • Financial Advisory Group left its Amgen share count unchanged in Q1 2024.
  • Amgen made up 0.05% of Financial Advisory Group's portfolio in Q1 2024, its #76 holding.
  • Financial Advisory Group first reported a position in Amgen in Q3 2018 and has held it in 20 quarters since.
  • Financial Advisory Group's Amgen position peaked at $299K in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.